ArticleERJ open research2024

Randomised, phase 1/2a trial of ION-827359, an antisense oligonucleotide inhibitor of ENaC.

Sivagurunathan Sutharsan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.